







Authors: Lisa Giovannini 1, Andrea Conti 2, Gianni Cappelli 1
1 University of Modena-ReggioEmilia, Nephrology, Dialysis and Transplantation, Modena, ITALY 
2 Modena Hospital, Department of Dermatology, Modena, ITALY
Psoriasis is a chronic inflammatory 
dermatosis with increased risk of  
comorbidities including diabetes, 
dyslipidemia, non-alcoholic fatty liver 
disease and metabolic syndrome, but 
there are limited data on kidney 
disease in psoriatic patients. 
In this study, we evaluated the 
prevalence of CKD and 
microalbuminuria in patients with 
psoriasis.
82 patients (53 men and 29 women; age range, 26-81 years; 
mean age 52.4 ± 13.9 years) with moderate and severe 
psoriasis, under conventional systemic treatment or biologics 
therapies, were enrolled in the study. 
Demographic characteristics of the psoriatic patients are given in 
Table 1. The mean duration of psoriasis was 18,4 ± 12,6 years 
and the mean PASI was 13,4 ± 9,4. SCr (mean sCr 0.89 ±
0.27mg/dl) as well the estimated CKD-EPI glomerular filtration 
rate (mean CKD-EPI eGFR 118.6 ± 120.7 ml/min) were within 
their normal ranges. Mean microalbuminuria was 32,1 ±
117,2mg/gr-creat. Twelve patients (14.6%) showed 
microalbuminuria >30mg/gr-creat. Patients with 
microalbuminuria showed longer time psoriasis (27.2 ± 11.8 vs 
16.5 ± 12.1 years; p = 0.005) and lower eGFR (80.1 ± 27.2 vs 
124.1 ± 129.5 ml/min; p=0.007), independent of other covariates 
such as age, sex, BMI, diabetes and hypertension. Age, gender, 
BMI, prevalence of hypertension and diabetes, PASI score and 
RCP were not significantly different between the group with or 
without microalbuminuria. There was a linear correlation 
between microalbuminuria and PASI score (r = 0.75, p = 0.008). 
Patients with microalbuminuria presented higher prevalence of 
psoriatic arthritis (58.3% vs 27.1%; p = 0.04) (Table2). 
Psoriatic patients with 
microalbuminuria showed longer 
time psoriasis and
lower CKD-EPI eGFR. 
Microalbuminuria is not common 
in patients with psoriasis but its 
positive correlation with psoriasis 
severity may suggest a 
subclinical glomerular 
dysfunction in these patients. 
Early detection of glomerular 
damage, when is minimal and/or 
a reversible stage is extremely 
important.
After Ethical Committee approval, eighty-
two patients received informed consent and 
participated in the study. All patients had 
blood drawn for serum creatinine (sCr) 
determination. Microalbuminuria (range 30-
300mg/gr of urine creatinine) was detected 
by turbidimetric immunoassay on first 
morning void urine samples. 
Psoriasis Area and Severity Index (PASI) 
scoring was used to assess the severity and 
extent of psoriasis. 
The Student’s t test and Chi-squared test 
were used to compare continuous and 
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